-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2024.
- Cytek Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$784K, a 135% decline year-over-year.
- Cytek Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$1.75M, a 1.18% increase year-over-year.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3.56M, a 191% decline from 2022.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.22M, a 142% decline from 2021.
- Cytek Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.91M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)